Methadone Clinics in Vermont

Methadone clinics in Vermont provide medically assisted treatment for opiate dependence that is proven to minimize the risk of relapse, reduce cravings and stop withdrawal symptoms from interrupting the recovery process.

Methadone Clinics in cities of Vermont

Finding Medication Treatment for Opioid Use Disorder in Vermont

Vermont treats opioid use disorder (OUD) through a statewide network built around one idea: no Vermonter should have to wait for care or drive hours to get it. That network is the Hub and Spoke system, which links nine regional Hubs with dozens of community Spoke practices so that medications for opioid use disorder (MOUD), methadone, buprenorphine, and naltrexone, are available across a mostly rural state.

The listings on this page connect you to programs near you. If you are not sure where to start, VT Helplink, the state’s free and confidential referral service, answers 24 hours a day, and the helpline on this page can point you to care.

How the Hub and Spoke System Works, and Where Each Medication Fits

Vermont’s Hub and Spoke system is the practical answer to the question most people are really asking: where do I actually go, and for which medication? The Vermont Blueprint for Health and the Department of Vermont Health Access built it, and it maps cleanly onto the two federal treatment settings.

The nine Hubs are opioid treatment programs (OTPs). Because federal law allows methadone for OUD only through a certified OTP, the Hubs are where methadone is started and dispensed, alongside intensive assessment, daily dosing when needed, and counseling. Hubs also offer buprenorphine and naltrexone. They are built for people with more complex needs or those beginning treatment.

The Spokes are office-based opioid treatment (OBOT): primary care practices, OB-GYN offices, and specialty clinics where a clinician prescribes buprenorphine (including Suboxone and other buprenorphine-naloxone products, plus extended-release injectable buprenorphine such as Sublocade) or naltrexone (including the monthly Vivitrol injection).

These prescriptions are filled at a regular pharmacy. Since a 2023 federal change, any clinician with a standard DEA registration can prescribe buprenorphine, which has widened where you can get it. People with less complex needs often start at a Spoke. Others move from a Hub to a Spoke as treatment stabilizes, and back if needs change.

To understand the trade-offs before you call, see how methadone and Suboxone compare and this overview of what an opioid treatment program provides. Which medication and setting fit you is a decision to make with a clinician.

State Rules, Insurance, and What Vermont Medicaid Covers

Vermont Medicaid, administered by the Department of Vermont Health Access, covers all three FDA-approved medications for OUD. For preferred buprenorphine products, no prior authorization is required unless the daily dose exceeds 16 mg.

The monthly Vivitrol injection does require prior authorization (Department of Vermont Health Access). The Hub and Spoke system itself runs on a Medicaid Health Home structure first approved in 2013, which is why care coordination and counseling are bundled into treatment rather than billed as extras.

Private insurance and Medicare also cover MOUD, and programs can discuss self-pay or sliding-scale options. Be sure to ask when you call. Federal rules updated in 2024 shape day-to-day treatment statewide. They expanded take-home methadone to up to a 28-day supply for patients who are stable in treatment, with eligibility decided by the program.

The expanded rules also allowed treatment to start by telehealth, authorized mobile medication units, and removed the old requirement that a person have a year-long history of opioid addiction before being admitted. As of July 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit.

Those flexibilities run through the end of 2026 and are still being finalized, so confirm current options with a provider. Methadone for OUD remains dispensed through an OTP.

Staying on a steady dose is what makes treatment work, and consistent dosing over time matters more than moving quickly toward stopping. If privacy at work is a concern, here is what employers can and cannot ask.

Vermont’s Overdose Picture, and Why Treatment Access is the Response

The trend in Vermont has turned. According to the Vermont Department of Health, 183 Vermonters died from an opioid-related overdose in 2024, down 22% from 236 in 2023, the second straight year of decline. Fentanyl remained the substance most often involved, present in 93% of those deaths.

State officials credit a broad network, including the Hub and Spoke system and the statewide naloxone distribution program, which put more than 70,000 doses of naloxone into communities in 2024 (Vermont Department of Health, 2025). Behind each figure is a person and a family, and the reason this page exists is that effective, local treatment for opioid addiction is available now, wherever you are in the state.

Starting Treatment and Finding a Program

Getting started usually begins with an assessment at a Hub, a Spoke, or by telehealth that looks at your history and helps match you to the right setting and medication. Because most people in Vermont use fentanyl, timing the first dose of buprenorphine matters, since starting too soon after using can trigger sudden, severe withdrawal (called precipitated withdrawal).

There is no need to be off opioids to begin methadone or buprenorphine. Use the city listings on this page to find the Hub or Spoke nearest you, or call VT Helplink. For a fuller picture of the levels of care available, see this guide to opioid addiction treatment options, which also distinguishes between residential and inpatient care if that is what you need.

Pregnancy, Incarceration, and Reentry

Two situations in Vermont carry specific, high-stakes needs. For pregnant Vermonters, methadone and buprenorphine are the recommended standard of care, and staying in treatment protects both parent and baby. A clinician and care team manage dosing through pregnancy and prepare for neonatal opioid withdrawal syndrome (NOWS), which is expected and treatable.

Fear of child-welfare involvement keeps some people from seeking care, but treatment is the protective step, and providers work within a Plan of Safe Care rather than against you. Here is more guidance on methadone and pregnancy, and how families can help.

Vermont has also extended Hub and Spoke into all of its state prisons, so treatment can start or continue during incarceration and connect to a community Hub or Spoke at release, the point when overdose risk is highest. A care coordinator arranges follow-up appointments and can send a bridge prescription to a pharmacy so there is no gap in medication.

Naloxone and Overdose Safety in Vermont

Naloxone, the medication that reverses an opioid overdose, is available across Vermont without a prescription under a statewide standing order (18 V.S.A. section 4240). You can get Narcan nasal spray at pharmacies, and it is stocked on the Vermont Medicaid preferred drug list with no prior authorization.

Community programs and syringe services distribute it free, and Vermont’s Good Samaritan law protects people who call for help during an overdose. A return to use is a common, manageable part of recovery, not a failure. Carrying naloxone is simple protection while treatment does its work. Learn the signs and steps in this overview of recognizing and responding to an overdose.

Common Questions About MOUD in Vermont

Where can I get methadone in Vermont?

Methadone for OUD is dispensed only through an opioid treatment program, which in Vermont means one of the nine regional Hubs. Buprenorphine and naltrexone are available more widely, at Hubs and at Spoke practices in communities across the state, and are filled at a pharmacy.

Does Vermont Medicaid pay for treatment?

Yes, Vermont Medicaid, through the Department of Vermont Health Access, covers methadone, buprenorphine, and naltrexone. Preferred buprenorphine products need no prior authorization under 16 mg per day. Vivitrol requires prior authorization. Private insurance and Medicare cover MOUD as well.

Can I start buprenorphine by telehealth?

As of July 2026, yes, including by phone in many cases and without a prior in-person visit. These federal flexibilities run through the end of 2026 and are still being finalized, so confirm what is current with the provider you contact.

Do I have to go in every day?

Not necessarily. Methadone patients who are stable in treatment can earn take-home doses, up to a 28-day supply under 2024 federal rules, with the schedule decided by the program. Buprenorphine and naltrexone from a Spoke are typically prescribed for weekly or monthly visits.

Is medication just trading one drug for another?

No, this is a common myth. Methadone and buprenorphine are prescribed at steady doses that stop withdrawal and cravings without the cycle of illicit use, and major medical bodies consider them the most effective treatment for OUD. You can read more in the site’s questions and answers and on how dependence differs from addiction.

Last reviewed and disclosures

Last reviewed July 2026.

Sources

Vermont Department of Health, Fatal Opioid Overdoses Among Vermonters Report, 2025 https://www.healthvermont.gov/sites/default/files/document/dsu-fatal-overdose-report-2025.pdf
Vermont Blueprint for Health, Hub and Spoke program description, Department of Vermont Health Access. https://blueprintforhealth.vermont.gov/about-blueprint/hub-and-spoke
Department of Vermont Health Access, Vermont Medicaid MOUD coverage and Preferred Drug List criteria. https://dvha.vermont.gov/providers/pharmacy/preferred-drug-list-pdl-clinical-criteria
Department of Vermont Health Access, naloxone standing order under 18 V.S.A. section 4240 and preferred drug list. https://www.healthvermont.gov/sites/default/files/document/eprip-naloxone-standing-order.pdf
SAMHSA and DEA, 42 CFR Part 8 (2024) and buprenorphine telemedicine rules current through 2026. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8
FDA medications for opioid use disorder overview. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/information-about-medications-opioid-use-disorder-moud

MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. MethadoneCenters.com is not owned or operated by any treatment facility and does not endorse any treatment facility or guarantee the quality of care provided, or the results to be achieved, by any treatment facility. The information provided is not a substitute for professional treatment advice.

Calls to any general helpline on this site will be answered or returned by a paid advertiser. By calling the helpline, you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.

Call For Help With Addiction

Talk To Someone Now